Published in Metab Brain Dis on April 21, 2017
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci (2006) 12.23
The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron (2008) 10.19
A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med (2012) 8.04
A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A (1999) 7.48
Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet (2000) 6.61
Glial regulation of the cerebral microvasculature. Nat Neurosci (2007) 5.91
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci (2011) 5.64
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A (2003) 5.44
Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol (2003) 4.71
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci Transl Med (2011) 4.07
Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron (1993) 3.92
Metabolism and functions of glutathione in brain. Prog Neurobiol (2000) 3.74
Uniquely hominid features of adult human astrocytes. J Neurosci (2009) 3.49
Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res (2004) 3.30
Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci (2004) 3.09
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol (2008) 2.90
ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev (2005) 2.76
Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell (2013) 2.71
High cholesterol level is essential for myelin membrane growth. Nat Neurosci (2005) 2.34
Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. Neuron (2015) 2.09
Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc Natl Acad Sci U S A (2007) 2.06
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest (2008) 2.01
Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem (2007) 1.98
Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J Biol Chem (2006) 1.98
Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J Biol Chem (2005) 1.91
Aquaporin-4-deficient mice have increased extracellular space without tortuosity change. J Neurosci (2008) 1.87
Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol Chem (2004) 1.82
Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med (2006) 1.72
Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse. Neuroscience (1998) 1.68
The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol Cell Neurosci (2007) 1.66
Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci (1998) 1.61
Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu Rev Biochem (2009) 1.61
Lipid imbalance in the neurological disorder, Niemann-Pick C disease. FEBS Lett (2006) 1.57
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain (2007) 1.55
Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res (2000) 1.51
Cholesterol metabolism in neurons and astrocytes. Prog Lipid Res (2011) 1.48
Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem (2004) 1.46
Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J Biol Chem (2004) 1.45
Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J Neurosci (2010) 1.38
Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res (2001) 1.37
LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul Pharmacol (2002) 1.35
Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol Cell Neurosci (2009) 1.35
Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model. J Neurosci (2013) 1.32
High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol (2006) 1.31
24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J Biol Chem (2006) 1.28
Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells. Neuroreport (2006) 1.26
Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis. J Cell Mol Med (2011) 1.24
Specific regional transcription of apolipoprotein E in human brain neurons. Am J Pathol (1999) 1.24
Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim Biophys Acta (2010) 1.23
Obesity and vascular dysfunction. Pathophysiology (2008) 1.23
Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele. PLoS One (2012) 1.22
Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene (2012) 1.19
Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J Neurochem (2009) 1.15
Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model. J Neurochem (2004) 1.12
The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress. J Neurochem (2001) 1.09
Redox modulatory site of the NMDA receptor-channel complex: regulation by oxidized glutathione. J Neurosci Res (1991) 1.09
Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J Biol Chem (2006) 1.08
Origin of cholesterol in myelin. Neurochem Res (1996) 1.08
Cholesterol: its regulation and role in central nervous system disorders. Cholesterol (2012) 1.08
Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clin Neuropathol (2001) 1.07
On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci Lett (2001) 1.05
Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. Neuroreport (2000) 1.04
The choroid plexus and cerebrospinal fluid: emerging roles in development, disease, and therapy. J Neurosci (2013) 1.03
Evidence that the major membrane lipids, except cholesterol, are made in axons of cultured rat sympathetic neurons. J Neurochem (1994) 1.01
Apolipoprotein E receptors in the nervous system. Curr Opin Lipidol (2009) 1.01
Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis (2006) 1.00
Age-dependent and tissue-related glutathione redox status in a mouse model of Alzheimer's disease. J Alzheimers Dis (2012) 1.00
High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis (2014) 0.99
Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis? CNS Spectr (2008) 0.99
Genetic connections between neurological disorders and cholesterol metabolism. J Lipid Res (2010) 0.98
Differential expression of two glial glutamate transporters in the rat brain: an in situ hybridization study. Eur J Neurosci (1994) 0.98
Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain. J Proteome Res (2010) 0.98
Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease. J Alzheimers Dis (2012) 0.95
Effects of a disrupted blood-brain barrier on cholesterol homeostasis in the brain. J Biol Chem (2014) 0.94
Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease. Acta Neurol Scand (2003) 0.92
Glutathione efflux from cultured astrocytes. J Neurochem (1996) 0.92
Cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis. Biochim Biophys Acta (2012) 0.92
Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene. J Mol Neurosci (2004) 0.91
Low-density lipoprotein receptor-related protein-1: role in the regulation of vascular integrity. Arterioscler Thromb Vasc Biol (2014) 0.89
Higher incidence of mild cognitive impairment in familial hypercholesterolemia. Am J Med (2010) 0.89
Diabetes drugs and neurological disorders: new views and therapeutic possibilities. Lancet Diabetes Endocrinol (2013) 0.88
Oxidative stress related changes in the brain of hypercholesterolemic rabbits. Biofactors (2008) 0.87
Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes. Proc Natl Acad Sci U S A (2016) 0.87
Prenatal high-fat diet alters the cerebrovasculature and clearance of β-amyloid in adult offspring. J Pathol (2015) 0.86
Membrane-bound enzymes of cholesterol synthesis from lanosterol. Biochem Biophys Res Commun (2002) 0.85
Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J Clin Invest (2016) 0.85
Absence of ApoE upregulates murine brain ApoD and ABCA1 levels, but does not affect brain sterol levels, while human ApoE3 and human ApoE4 upregulate brain cholesterol precursor levels. J Alzheimers Dis (2009) 0.84
Replacing the cholesterol hydroxyl group with the ketone group facilitates sterol flip-flop and promotes membrane fluidity. J Phys Chem B (2008) 0.84
24(S)-hydroxycholesterol is actively eliminated from neuronal cells by ABCA1. J Neurochem (2013) 0.84
Increased acidic fibroblast growth factor concentrations in the serum and cerebrospinal fluid of patients with Alzheimer's disease. J Clin Neurosci (2010) 0.83
Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders. CNS Neurosci Ther (2014) 0.82
Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease. Expert Opin Ther Targets (2013) 0.81
Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease. Biochem Biophys Res Commun (2013) 0.81
Dual pathways mediate β-amyloid stimulated glutathione release from astrocytes. Glia (2015) 0.80
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits. Mol Neurodegener (2015) 0.80
Regulation of hippocampal cholesterol metabolism by apoE and environmental stimulation. J Neurochem (2005) 0.80
The astrocytic contribution to neurovascular coupling--still more questions than answers? Neurosci Res (2013) 0.78
Changes in astrocyte functional markers and β-amyloid metabolism-related proteins in the early stages of hypercholesterolemia. Neuroscience (2015) 0.78
Increased susceptibility to amyloid-β-induced neurotoxicity in mice lacking the low-density lipoprotein receptor. J Alzheimers Dis (2014) 0.76